Trenbolone acetate

Overview

Trenbolone acetate, sold under brand names such as Finajet and Finaplix among others, is an androgen and anabolic steroid (AAS) medication used in veterinary medicine, specifically to increase the profitability of livestock by promoting muscle growth in cattle. It is given by injection into muscle.[1–4] WP

Side effects of trenbolone acetate include symptoms of masculinization like acne, increased body hair growth, scalp hair loss, voice changes, and increased sexual desire. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and highly androgenic effects, as well as potent progestogenic effects, and weak glucocorticoid effects. Trenbolone acetate is an androgen ester and a short-lasting prodrug of trenbolone in the body.[1][4–8] WP

Trenbolone acetate was discovered in 1963 and was introduced for veterinary use in the early 1970s. In addition to its veterinary use, trenbolone acetate is used to improve physique and performance, for which purpose it is purchased from black market suppliers. The drug is a controlled substance in many countries and so non-veterinary use is generally illicit.[4][9][10] WP

Uses, dosage and effects

Veterinary uses

In the livestock industry, trenbolone acetate is more often called Finaplix. It was intentionally developed to promote androgen and gain muscle mass in cattle. Due to its properties, this allows livestock to grow as much muscle as possible before they are transported to a slaughterhouse. WP

Methyl cellulose and yellow dye are usually present in pellets given to livestock. A single dosage generally consists of ten pellets, and a package of Finaplix usually consists of one cartridge containing one hundred pellets. The medication is administered by subcutaneous injection into the posterior ear using an implanter gun. Finaplix is consistently implanted until the animal is ready to be slaughtered. There is no withholding period. Due to the common practice of trenbolone acetate use in veterinary medicine, it is quite common to find traces of trenbolone metabolites in cattle worldwide.[9][11] WP⚠ Wikipedia itself has flagged this text: clarification needed.

Bodybuilding

Trenbolone acetate has never been approved for use in humans (but another ester of Trenbolone called Trenbolone hexahydrobenzylcarbonate was, for a short period of time under the name “Parabolan”, during the 1980's, up until its discontinuation in 1997.) therefore guidelines for human consumption do not exist. However, athletes and bodybuilders have been using trenbolone acetate as a physique- and performance-enhancing drug for decades. Some argue there are many benefits for bodybuilders using trenbolone acetate as an AAS. Unlike exogenous testosterone, trenbolone acetate does not cause fluid retention, so bodybuilders appear leaner; therefore, it is more commonly used during preparation for competitive events. Trenbolone acetate does not convert into an estrogenic metabolite; thus there are no estrogenic side effects. Trenbolone enanthate is a commonly used AAS and lasts much longer than trenbolone acetate with intramuscular injection.[4][9] WP

Medical uses

Trenbolone acetate was never approved for use in humans and hence has no medical uses. However, as an AAS, it would be expected to be effective for treating indications in which other AAS are useful, such as androgen deficiency, wasting syndromes, muscle atrophy, and certain types of anemia.[4][12] WP

Trenbolone hexahydrobenzylcarbonate was previously produced for human use by Negma Pharmaceuticals of France in 1.5 ml ampoules containing 76.5 mg of the steroid. WP⚠ Wikipedia itself has flagged this text: citation needed.

Risks and side effects

Side effects

Trenbolone acetate, like any other AAS, has many side effects. Its strong androgenic properties stimulate virilization, making it unsuitable for women pursuing physique or performance enhancement. The side effects of trenbolone acetate are similar to other AAS; however, the negative side effects specific to trenbolone acetate are as follows:[4][6][13][14] WP

Androgenic

Trenbolone acetate has androgenic activity. Common side effects include oily skin, acne, seborrhea, increased facial or body hair growth, and accelerated scalp hair loss. Severity of these side effects varies based on an individual's genetics. Men susceptible to hair loss have a higher chance of becoming permanently bald. In women, voice deepening, hirsutism, clitoral enlargement, and general virilization may occur.[4][6][15–18] WP

Hypogonadism

Trenbolone acetate contributes greatly to development of muscle mass and feed efficiency; however, administration of any AAS suppresses natural testosterone production and therefore has the potential to cause hypogonadism.[4][13][18] WP

Cardiovascular

Administration of any AAS can lead to cardiovascular issues. Trenbolone acetate can have a strongly negative impact on cholesterol levels by suppressing high-density lipoprotein (HDL) cholesterol production and stimulating low-density lipoprotein (LDL) cholesterol production. When compared to oral AAS, trenbolone acetate exerts a stronger negative effect on cholesterol levels.[19][20][21] WP

"tren cough"

The exact mechanisms underlying "tren cough" are not known; however, trenbolone acetate's androgenic effect activates a variety of lipid-like active compounds called prostaglandins, many of which are inflammatory and vasoconstrictive. Prostaglandins act on two signaling pathways: cyclooxygenase (COX) (also known as prostaglandin-endoperoxide synthase) and lipoxygenase (LOX) (EC 1.13.11.34, EC 1.13.11.33, etc.). The bradykinin peptide is well known to promote a cough reaction associated with ACE inhibitors prescribed for hypertension.[22][23][24] WP⚠ Part of this sentence could not be copied from the source. Open the source to read it in full.

Estrogenic and progestogenic

Trenbolone is not estrogenic; therefore, use does not lead to excess fluid retention. However, due to trenbolone's potent progestogenic activity (it binds with high affinity to the progesterone receptor), gynecomastia, characterized by development and swelling of breast tissue, may occur.[4][9][17][25] WP⚠ Wikipedia itself has flagged this text: citation needed.

Pharmacology

Pharmacodynamics

Trenbolone acetate is a prodrug of trenbolone. Like other AAS, trenbolone is an agonist of the androgen receptor (AR) and hence has anabolic and androgenic activity as well as antigonadotropic activity. The potency of Trenbolone is not known, although it's often falsely believed to be five times higher than testosterone. This is based on a book by William Llewellyn but has not been definitively proven. Trenbolone was never approved for human use, and therefore limited data on the subject exists. The available research is mostly in rats, which makes the 500/100 potency number inaccurate, as rats respond differently to, and are less sensitive to, androgens. While some literature reports a 5-fold higher potency, two other scientific reviews report a 3-fold higher potency, which makes it unclear how large the relative potency actually is. Trenbolone is an agonist of the progesterone receptor (PR), and in relation to this, has moderate to strong progestogenic activity. Conversely, trenbolone acetate is not a substrate for aromatase and hence lacks estrogenic activity. The compound also has weak glucocorticoid activity.[1][4][7][8][16][26][27][28] WP

Similar to many other AAS, trenbolone acetate has the capability to produce insulin-like growth factor-1 (IGF-1). This naturally produced protein-based hormone affects every cell in the body of an organism and plays a large role in muscle recovery and rejuvenation. Extreme muscle growth and cell splitting compared is facilitated through trenbolone acetate administration when compared to other AAS. The facilitation of IGF-1 plays a significant role in the functions and properties of the central nervous system, pulmonary system, muscle tissue, ligaments, cartilage, and tendons.[29][30] WP

Trenbolone acetate also has the ability to increase red blood cell count. With a larger amount of red blood cells, blood oxygenation is enhanced. This allows for enhanced muscular endurance and therefore promotes a faster rate of recovery. Trenbolone acetate is capable of inhibiting glucocorticoids such as cortisol. The properties of glucocorticoid are the opposite of androgens as muscle tissue depletion and fat gain is promoted. Administration of trenbolone acetate aims at decreasing the production of glucocorticoid hormones. Trenbolone acetate’s contribution to feed efficiency, also known as nutrient efficiency is what makes it an attractive AAS used for agricultural purposes. Food is one of the most anabolic substances that any living organism can consume, and therefore with the administration of trenbolone acetate, every nutrient in the body becomes a lot more valuable. This facilitates an organism's body that is exposed to the AAS to make better use of the nutrients already consumed.[9][31][32] WP⚠ Wikipedia itself has flagged this text: citation needed.

Pharmacokinetics

The acetate ester of trenbolone acetate allows for slow release post injection. This ester gives trenbolone an activated elimination half-life of about 3 days.[33] WP

History

History

Trenbolone acetate was first synthesized in 1963 and approved by the livestock industry as a growth promoter for beef cattle in the early 1970s. During this period of its first administration, trenbolone acetate was sold under the names Finajet and Finaject. The original manufacturer of trenbolone acetate discontinued during the late 1980s and administered the synthesis of subcutaneous pellets called Finaplix. These pellets aimed to increase muscle mass and lean tissue of cattle prior to slaughter to increase the profitability of livestock when measured in total pounds of meat sold.[4][9][10] WP

The drug appears to have been an early development project of Roussel Uclaf, a French pharmaceutical company, and by the early 1970s, it was being sold as an injectable. There are a number of trenbolone esters but trenbolone acetate is the only one known to be produced in veterinary AAS manufacturers.[17] WP

Trenbolone acetate became popular among bodybuilders and athletes during the early 1980s. During this period, the AAS was transported illegally from Europe in large quantities. Although trenbolone acetate was very popular for a short amount of time, the large amounts of supplies were discontinued in 1987. This decision was based upon the public concern of sports doping and its negative effects on athletes.[4][9] WP

Legal status

Generic names

Trenbolone acetate is the generic name of the drug and its USAN (United States Adopted Name), USP (United States Pharmacopeia), and BANM (British Approved Name).[2][3][34][35] WP

Brand names

Trenbolone acetate is or has been sold alone for veterinary use under the brand names Component TH, Component TS, Finaject, Finajet, Finaplix-H, and Finaplix-S. It is or has also been sold in combination with estradiol or estradiol benzoate for veterinary use under the brand names Revalor and Synovex.[2][3][4][34][35] WP

Distribution and regulation

Trenbolone acetate, specifically referred to as Finaplix in the livestock industry, is available to purchase in veterinary drug markets. A typical cartridge usually comes in the form of 20 mg pellets. It generally comes in the form of implant pellets containing 20 mg of trenbolone acetate each. Preparations containing trenbolone acetate remain rare since its decline in production after the 1980s. Using AAS for any other purpose, or without a doctor's prescription, is illegal in most countries. Major sporting and bodybuilding organizations ban the use of controlled AAS, and the possession or sale of drugs can lead to arrest and conviction of drug-trafficking in many countries, including the United States and Australia. However, in the United Kingdom and Canada, owning AAS for personal use as a bodybuilding supplement is not illegal, but selling the AAS without a valid medical license or reason is still against the law.[4][34][36] WP

Doping in sports

Regardless of their legality, AAS are still banned by most sporting leagues in the country, who routinely conduct drug tests to find the users of any AAS. There are known cases of doping in sports with trenbolone acetate by professional athletes. WP

Chemistry

Formula

C20H24O3 PC

CAS number

10161-34-9 PC

Molar mass (g/mol)

312.4 PC

IUPAC name (computed by PubChem)

[(8S,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate PC

SMILES

CC(=O)O[C@H]1CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C PC

InChIKey

CMRJPMODSSEAPL-FYQPLNBISA-N PC

PubChem CID

66359

Harm reduction information

No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.

User reports

Pop culture

No references added yet.

Sources

1. Journal / agency Yarrow JF, McCoy SC, Borst SE. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity. Steroids. June 2010. doi:10.1016/j.steroids.2010.01.019 · PMID 20138077
2. Other Morton IK, Hall JM. Concise Dictionary of Pharmacological Agents: Properties and Synonyms. 6 December 2012
3. Other Trenbolone
4. Other Llewellyn W. Anabolics. 2011
5. Journal / agency Zarkawi M, Galbraith H, Hutchinson JS. The action of trenbolone acetate, a synthetic anabolic steroid, on ovarian function in the guinea pig. Laboratory Animals. April 1991. doi:10.1258/002367791781082586 · PMID 1857092
6. Journal / agency Kicman AT. Pharmacology of anabolic steroids. British Journal of Pharmacology. June 2008. doi:10.1038/bjp.2008.165 · PMID 18500378 · PMC2439524
7. Journal / agency Meyer HH, Rapp M. Reversible binding of the anabolic steroid trenbolone to steroid receptors. European Journal of Endocrinology. 1985. doi:10.1530/acta.0.109S129
8. Journal / agency Delettré J, Mornon JP, Lepicard G, Ojasoo T, Raynaud JP. Steroid flexibility and receptor specificity. Journal of Steroid Biochemistry. January 1980. doi:10.1016/0022-4731(80)90112-0 · PMID 7382482
9. Journal / agency Robinson JA, Ma Q, Staveley JP, Smolenski WJ, Ericson J. Degradation and transformation of 17α-trenbolone in aerobic water-sediment systems. Environmental Toxicology and Chemistry. March 2017. doi:10.1002/etc.3381 · PMID 26800846
10. Journal / agency Durhan EJ, Lambright CS, Makynen EA, Lazorchak J, Hartig PC, Wilson VS, Gray LE, Ankley GT. Identification of metabolites of trenbolone acetate in androgenic runoff from a beef feedlot. Environmental Health Perspectives. April 2006. doi:10.1289/ehp.8055 · PMID 16818248 · PMC1874171
11. Journal / agency Jeong SH, Kang D, Lim MW, Kang CS, Sung HJ. Risk assessment of growth hormones and antimicrobial residues in meat. Toxicological Research. December 2010. doi:10.5487/TR.2010.26.4.301 · PMID 24278538 · PMC3834504
12. Journal / agency Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. The Journal of Clinical Endocrinology and Metabolism. November 2001. doi:10.1210/jcem.86.11.7983 · PMID 11701661
13. Journal / agency Spranger B, Metzler M. Disposition of 17 beta-trenbolone in humans. Journal of Chromatography. April 1991. doi:10.1016/0378-4347(91)80517-G · PMID 1874853
14. Other Trenbolone Acetate - A comprehensive list of side effects. 21 June 2020
15. Journal / agency Gasparini M, Curatolo M, Assini W, Bozzoni E, Tognoli N, Dusi G. Confirmatory method for the determination of nandrolone and trenbolone in urine samples using immunoaffinity cleanup and liquid chromatography-tandem mass spectrometry. Journal of Chromatography A. November 2009. doi:10.1016/j.chroma.2009.04.075 · PMID 19447393
16. Journal / agency Bauer ER, Daxenberger A, Petri T, Sauerwein H, Meyer HH. Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor. APMIS. December 2000. doi:10.1111/j.1600-0463.2000.tb00007.x · PMID 11252818
17. Journal / agency Richold M. The genotoxicity of trenbolone, a synthetic steroid. Archives of Toxicology. 1988. doi:10.1007/BF00364846 · PMID 3288174
18. Journal / agency Sillence MN, Rodway RG. Effects of trenbolone acetate and testosterone on growth and on plasma concentrations of corticosterone and ACTH in rats. The Journal of Endocrinology. September 1990. doi:10.1677/joe.0.1260461 · PMID 2170557
19. Journal / agency Payne JR, Kotwinski PJ, Montgomery HE. Cardiac effects of anabolic steroids. Heart. May 2004. doi:10.1136/hrt.2003.025783 · PMID 15084526 · PMC1768197
20. Journal / agency Donner DG, Elliott GE, Beck BR, Bulmer AC, Lam AK, Headrick JP, Du Toit EF. Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome. Endocrinology. January 2016. doi:10.1210/en.2015-1603 · PMID 26584015
21. Journal / agency Shahsavari Nia K, Rahmani F, Ebrahimi Bakhtavar H, Hashemi Aghdam Y, Balafar M. A Young Man with Myocardial Infarction due to Trenbolone Acetate; a Case Report. Emergency. 2014. PMID 26495342 · PMC4614617
22. Journal / agency Notelovitz M. Androgen effects on bone and muscle. Fertility and Sterility. April 2002. doi:10.1016/S0015-0282(02)02968-0 · PMID 12007900
23. Journal / agency Kam PC, See AU. Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia. May 2000. doi:10.1046/j.1365-2044.2000.01271.x · PMID 10792135
24. Journal / agency Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough. Nature Medicine. July 1996. doi:10.1038/nm0796-814 · PMID 8673930
25. Journal / agency Johnson RE, Murad MH. Gynecomastia: pathophysiology, evaluation, and management. Mayo Clinic Proceedings. November 2009. doi:10.4065/84.11.1010 · PMID 19880691 · PMC2770912
26. Other Llewellyn W. Anabolics. 2011
27. Other Wiebe JP. Reproduction and Adaptation: Topics in Human Reproductive Ecology. 2011-01-13
28. Journal / agency Neumann F. Pharmacological and endocrinological studies on anabolic agents. Environmental Quality and Safety. Supplement. 1976. PMID 782871
29. Journal / agency Kamanga-Sollo E, White ME, Hathaway MR, Chung KY, Johnson BJ, Dayton WR. Roles of IGF-I and the estrogen, androgen and IGF-I receptors in estradiol-17beta- and trenbolone acetate-stimulated proliferation of cultured bovine satellite cells. Domestic Animal Endocrinology. July 2008. doi:10.1016/j.domaniend.2008.02.003 · PMID 18403176
30. Journal / agency Sinnett-Smith PA, Dumelow NW, Buttery PJ. Effects of trenbolone acetate and zeranol on protein metabolism in male castrate and female lambs. The British Journal of Nutrition. September 1983. doi:10.1079/BJN19830092 · PMID 6193805
31. Journal / agency Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Molecular and Cellular Endocrinology. March 2011. doi:10.1016/j.mce.2010.04.005 · PMID 20398732 · PMC3047790
32. Journal / agency Griffiths TW. Effects of trenbolone acetate and resorcylic acid lactone on protein metabolism and growth in steers. Animal Production. 2010. doi:10.1017/S0003356100010254
33. Other Ruiz P, Strain EC. Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook. 2011
34. Other Elks J. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. 14 November 2014
35. Other Index Nominum 2000: International Drug Directory. January 2000
36. Other Anabolic Steroids

Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.